The prognostic value of C-reactive protein/albumin ratio in acute mesenteric Ischemia
dc.authorid | 0000-0002-9653-7958 | |
dc.contributor.author | Kaçer, İlker | |
dc.contributor.author | Çağlar, Ahmet | |
dc.contributor.author | Akıllı, Nazire Belgin | |
dc.date.accessioned | 2022-02-25T06:02:07Z | |
dc.date.available | 2022-02-25T06:02:07Z | |
dc.date.issued | 2023 | |
dc.department | Tıp Fakültesi | |
dc.description.abstract | Diagnosis of acute mesenteric ischemia (AMI) in its early stages is important for reversing ischemic damage. The CRP to albumin (CRP/Alb) ratio has been defined as an inflammatory indicator and is associated with the severity of inflammation and mortality rates. However, the prognostic value of CRP/Alb has not been evaluated in patients with AMI. Here, we aimed to examine the prognostic significance of CRP/Alb and compare it with other inflammatory markers. Materials and Methods: In this retrospective, case-control study, we included patients diagnosed with AMI at the emergency department between January 1, 2016, and December 31, 2020. In addition to demographic characteristics, lactate, D-dimer, white blood cell (WBC), CRP/Alb, and neutrophil/lymphocyte ratio (NLR) were recorded. Testing characteristics of CRP/Alb in predicting in-hospital mortality were studied. Results: The mean age of 132 patients was 66.48 ± 15.95 years and 71 (53.8%) of them were male. The cut-off value obtained using the receiver operating characteristic (ROC) curve for in-hospital mortality was a CRP/Alb ratio of >1.32 (sensitivity, 93.65%; specificity, 69.57%; +LR, 3.08; ?LR,.091; AUC,.782; 95% CI,.70-.85; P <.0001). The comparison of ROC curves between CRP/Alb and WBC, NLR, and lactate revealed a statistically significant difference (P <.05), whereas there was not any statistically significant difference between the ROC curves of CRP/Alb and D-dimer (P =.47). Conclusion: C-reactive protein/albumin ratio is a powerful predictor of in-hospital mortality for AMI patients. It was superior to WBC, NLR, and lactate. It could be used to determine low-risk patients and help clinicians with treatment options. | |
dc.identifier.doi | 10.1177/00031348221074220 | |
dc.identifier.endpage | - | en_US |
dc.identifier.issn | 0003-1348 | |
dc.identifier.issue | - | en_US |
dc.identifier.scopusquality | Q3 | |
dc.identifier.startpage | - | en_US |
dc.identifier.uri | https:/dx.doi.org/10.1177/00031348221074220 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12451/9229 | |
dc.identifier.volume | - | en_US |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | |
dc.publisher | SAGE Publications Inc. | |
dc.relation.ispartof | American Surgeon | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.subject | Acute Mesenteric Ischemia | |
dc.subject | Albumin | |
dc.subject | C-reactive Protein | |
dc.subject | D-dimer | |
dc.subject | Neutrophil/lymphocyte Ratio | |
dc.subject | In-hospital Mortality | |
dc.title | The prognostic value of C-reactive protein/albumin ratio in acute mesenteric Ischemia | |
dc.type | Article |